On October 17, 2025, BiomX Inc. reported the successful election of three Class II directors, authorization for a reverse stock split between 1-for-5 and 1-for-20, and ratification of Kesselman & Kesselman as its public accounting firm for 2025. All proposals were approved by stockholders with significant support.